Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT03873493
Title A Study Evaluating the Efficacy of Venetoclax Plus Ibrutinib in Subjects With T-cell Prolymphocytic Leukemia
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors AbbVie
Age Groups: senior | adult
Covered Countries USA | ITA | GBR | FRA | DEU | AUT | AUS

Facility Status City State Zip Country Details
Dana-Farber Cancer Institute /ID# 207728 Boston Massachusetts 02215 United States Details
Mayo Clinic - Rochester /ID# 207692 Rochester Minnesota 55905-0001 United States Details
University of Texas MD Anderson Cancer Center /ID# 207746 Houston Texas 77030 United States Details
Peter MacCallum Cancer Ctr /ID# 209554 Melbourne Victoria 3000 Australia Details
Medizinische Universitaet Wien /ID# 208497 Vienna Wien 1090 Austria Details
Helsinki University Hospital /ID# 208108 Helsinki Uusimaa 00290 Finland Details
HCL - Hôpital Lyon Sud /ID# 208731 Pierre Benite CEDEX Auvergne-Rhone-Alpes 69495 France Details
CHRU Lille - Hopital Claude Huriez /ID# 208726 Lille Hauts-de-France 59037 France Details
Hopital Pitie Salpetriere /ID# 208730 Paris 75013 France Details
University Hospital Cologne /ID# 208834 Cologne 50937 Germany Details
Azienda Sanitaria Universitaria Giuliano Isontina /ID# 211487 Trieste 34128 Italy Details
Maxima Medisch Centrum /ID# 207989 Eindhoven 5631 BM Netherlands Details
Universitair Medisch Centrum Groningen /ID# 207990 Groningen 9713 GZ Netherlands Details
Oxford University Hospitals NHS Foundation Trust /ID# 211264 Oxford Oxfordshire OX3 9DU United Kingdom Details
The Royal Marsden NHS Foundation Trust /ID# 211263 London SW3 6JJ United Kingdom Details
*Shaded cells indicate that there was no data available from for the field